Directly observed antiretroviral therapy: a systematic review and meta-analysis of randomised clinical trials (Q37642979)

21 August 2017

0 references

1 reference

title

Directly observed antiretroviral therapy: a systematic review and meta-analysis of randomised clinical trials (English)

1 reference

21 August 2017

main subject

anti-retroviral agent

0 references

0 references

1 reference

Mark E Engel

3

0 references

Edward J. Mills

series ordinal

4

object named as

Edward J Mills

1 reference

21 August 2017

1

Nathan Ford

1 reference

21 August 2017

Jean B Nachega

2

1 reference

21 August 2017

language of work or name

English

0 references

publication date

30 November 2009

1 reference

21 August 2017

1 reference

21 August 2017

volume

374

1 reference

21 August 2017

issue

9707

1 reference

21 August 2017

page(s)

2064-2071

1 reference

Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961671-8

7 January 2021

Adherence to nonnucleoside reverse transcriptase inhibitor-based HIV therapy and virologic outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961671-8

7 January 2021

Predictors of HIV drug-resistance mutations in a large antiretroviral-naive cohort initiating triple antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961671-8

7 January 2021

Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961671-8

7 January 2021

Efficacy of interventions in improving highly active antiretroviral therapy adherence and HIV-1 RNA viral load. A meta-analytic review of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961671-8

7 January 2021

Doubts about DOT: antiretroviral therapy for resource-poor countries

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961671-8

7 January 2021

Directly administered antiretroviral therapy in the treatment of HIV infection: benefit or burden?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961671-8

7 January 2021

Directly observed therapy for tuberculosis: history of an idea

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961671-8

7 January 2021

Directly observed therapy for treating tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961671-8

7 January 2021

Critical reflections on evidence, ethics and effectiveness in the management of tuberculosis: public health and global perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961671-8

7 January 2021

Does blinding of readers affect the results of meta-analyses? University of Pennsylvania Meta-analysis Blinding Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961671-8

7 January 2021

Adherence to Medication

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961671-8

7 January 2021

Agreement between alternative classifications of acute respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961671-8

7 January 2021

Overcoming the limitations of current meta-analysis of randomised controlled trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961671-8

7 January 2021

The statistical basis of meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961671-8

7 January 2021

Estimating the mean and variance from the median, range, and the size of a sample

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961671-8

7 January 2021

Response to zidovudine/didanosine-containing combination antiretroviral therapy among HIV-1 subtype C-infected adults in Botswana: two-year outcomes from a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961671-8

7 January 2021

A randomized trial of directly administered antiretroviral therapy and adherence case management intervention

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961671-8

7 January 2021

A randomized clinical trial of community-based directly observed therapy as an adherence intervention for HAART among substance users

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961671-8

7 January 2021

Randomized control trial of peer-delivered, modified directly observed therapy for HAART in Mozambique

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961671-8

7 January 2021

Short- and long-term efficacy of modified directly observed antiretroviral treatment in Mombasa, Kenya: a randomized trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961671-8

7 January 2021

Persistence of virological benefits following directly administered antiretroviral therapy among drug users: results from a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961671-8

7 January 2021

Modified directly observed antiretroviral therapy compared with self-administered therapy in treatment-naive HIV-1-infected patients: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961671-8

7 January 2021

Superiority of directly administered antiretroviral therapy over self-administered therapy among HIV-infected drug users: a prospective, randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961671-8

7 January 2021

Directly administered antiretroviral therapy for HIV-infected drug users does not have an impact on antiretroviral resistance: results from a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961671-8

7 January 2021

Adherence and antiretroviral therapy in injection drug users

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961671-8

7 January 2021

Attitudes to directly observed antiretroviral treatment in a workplace HIV care programme in South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961671-8

7 January 2021

Cue-dose training with monetary reinforcement: pilot study of an antiretroviral adherence intervention

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961671-8

7 January 2021

Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961671-8

7 January 2021

A Simple, Dynamic Measure of Antiretroviral Therapy Adherence Predicts Failure to Maintain HIV‐1 Suppression

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961671-8

7 January 2021

The relationship between resistance and adherence in drug-naive individuals initiating HAART is specific to individual drug classes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961671-8

7 January 2021

Treatment of tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961671-8

7 January 2021

Modified directly observed therapy to facilitate highly active antiretroviral therapy adherence in Beira, Mozambique. Development and implementation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961671-8

7 January 2021

10.1016/S0140-6736(09)61671-8

Identifiers

DOI

1 reference

21 August 2017

1 reference